{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:00:19Z","timestamp":1786593619189,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/pai.0b013e3182389663","type":"journal-article","created":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T15:30:55Z","timestamp":1327678255000},"page":"308-312","source":"Crossref","is-referenced-by-count":7,"title":["Primary Mucinous Adenocarcinoma of the Epididymis"],"prefix":"10.1097","volume":"23","author":[{"given":"Sarika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pay Chin","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Yung","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richie","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/B:UROL.0000032675.79615.ef","article-title":". Primary adenocarcinoma of the epididymis: case report.","volume":"36","author":"Arisan","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"R2-10-20210126","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/00000478-199712000-00010","article-title":"Adenocarcinoma of the epididymis: a report of four cases and review of the literature.","volume":"21","author":"Jones","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R3-10-20210126","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1373\/clinchem.2003.030700","article-title":". Microsatellite instability in colorectal cancer: considerations for molecular diagnosis and high-throughput screening of archival tissues.","volume":"50","author":"Salto-Tellez","year":"2004","journal-title":"Clin Chem"},{"key":"R4-10-20210126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2353\/jmoldx.2006.050092","article-title":". Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers.","volume":"8","author":"Murphy","year":"2006","journal-title":"J Mol Diagn"},{"key":"R5-10-20210126","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/1078-0432.CCR-05-1981","article-title":". Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.","volume":"12","author":"Tam","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R6-10-20210126","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2407-6-295","article-title":". High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.","volume":"6","author":"Krypuy","year":"2006","journal-title":"BMC Cancer"},{"key":"R7-10-20210126","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":". Mutations of the BRAF gene in human cancer.","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"R8-10-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-022X(00)00153-6","article-title":"Mutation analysis of p53 in ovarian tumors by DHPLC.","volume":"47","author":"Gross","year":"2001","journal-title":"J Biochem Biophys Methods"},{"key":"R9-10-20210126","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.urology.2004.12.061","article-title":"Basaloid carcinoma of epididymis.","volume":"65","author":"Kamal","year":"2005","journal-title":"Urology"},{"key":"R10-10-20210126","first-page":"242","article-title":". Undifferentiated Primary Carcinoma of the Epididymis Treated with Sequential Chemoradiotherapy: A Case Report.","volume":"19","author":"Zengin","year":"2009","journal-title":"Int J Hematol Oncol"},{"key":"R11-10-20210126","first-page":"199","article-title":"Columnar carcinoma of the epididymis.","volume":"1","author":"Colby","year":"1907","journal-title":"Br Med J"},{"key":"R12-10-20210126","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-5347(17)37173-2","article-title":". Papillary cystadenocarcinoma of the epididymis: a case report and review of the literature.","volume":"147","author":"Yu","year":"1992","journal-title":"J Urol"},{"key":"R13-10-20210126","first-page":"440","article-title":". Papillary adenocarcinoma of the epididymis.","volume":"43","author":"Kurihara","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"R14-10-20210126","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0090-4295(98)00275-1","article-title":"Primary adenocarcinoma of the epididymis: case report and review of the literature.","volume":"52","author":"Ganem","year":"1998","journal-title":"Urology"},{"key":"R15-10-20210126","first-page":"1360","article-title":"Bilateral mucinous cystadenocarcinoma of the testis and epididymis.","volume":"116","author":"Nistal","year":"1992","journal-title":"Arch Pathol Lab Med"},{"key":"R16-10-20210126","first-page":"456","article-title":"Papillary cystadenoma of the epididymis. A clinicopathologic analysis of 20 cases.","volume":"91","author":"Price","year":"1971","journal-title":"Arch Pathol"},{"key":"R17-10-20210126","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0046-8177(95)90299-6","article-title":". Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis.","volume":"26","author":"Gilcrease","year":"1995","journal-title":"Hum Pathol"},{"key":"R18-10-20210126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/path.2029","article-title":". Epididymal cystadenomas and epithelial tumourlets: effects of VHL deficiency on the human epididymis.","volume":"210","author":"Glasker","year":"2006","journal-title":"J Pathol"},{"key":"R19-10-20210126","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000478-198408000-00006","article-title":"Adenocarcinoma of the rete testis. Case report, ultrastructural observations, and clinicopathologic correlates.","volume":"8","author":"Nochomovitz","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"R20-10-20210126","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4161\/cbt.5.8.3251","article-title":". Recurrent KRAS codon 146 mutations in human colorectal cancer.","volume":"5","author":"Edkins","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"R21-10-20210126","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-05-0404","article-title":". Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.","volume":"65","author":"Samowitz","year":"2005","journal-title":"Cancer Res"},{"key":"R22-10-20210126","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1200\/JCO.2004.02.154","article-title":". Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.","volume":"22","author":"Nagasaka","year":"2004","journal-title":"J Clin Oncol"},{"key":"R23-10-20210126","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.11523","article-title":". Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.","volume":"108","author":"Koinuma","year":"2004","journal-title":"Int J Cancer"},{"key":"R24-10-20210126","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: a model for targeted therapy.","volume":"12","author":"Scaltriti","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R25-10-20210126","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer.","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"R26-10-20210126","doi-asserted-by":"crossref","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use.","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R27-10-20210126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.2784","article-title":"The role of mutant p53 in human cancer.","volume":"223","author":"Goh","year":"2011","journal-title":"J Pathol"},{"key":"R28-10-20210126","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":". Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"R29-10-20210126","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09553000902954504","article-title":"Is there a specific mutation of p53 gene due to radon exposure A systematic review.","volume":"85","author":"Ruano-Ravina","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"R30-10-20210126","first-page":"1","article-title":". Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.","volume":"53","author":"Horio","year":"1993","journal-title":"Cancer Res"},{"key":"R31-10-20210126","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.leu.2404524","article-title":". Clinical significance of TP53 mutation in myeloma.","volume":"21","author":"Chng","year":"2007","journal-title":"Leukemia"},{"key":"R32-10-20210126","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1095-1029","article-title":". Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy.","volume":"1","author":"Bergh","year":"1995","journal-title":"Nat Med"}],"container-title":["Applied Immunohistochemistry & Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00129039-201504000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:33:12Z","timestamp":1786048392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129039-201504000-00010"}},"subtitle":["Report of a Rare Case With Molecular Genetic Characterization Including Mutation Analysis of the TP53 Gene"],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0b013e3182389663","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}